Results 211 to 220 of about 148,802 (383)

Clinical efficacy and safety of pantoprazole versus ranitidine in patients with gastroesophageal reflux disease: Spanish multicenter study

, 2000
Pedro Menchén, Juan R. Malagelada, José Ramón Armengol, Leopoldo Martín, Arturo Pérez, Miguel Muñoz‐Navas, Arturo Sánchez, José M. Masse   +7 more
openalex   +1 more source

Spastic Esophageal Disorders—How Much Muscle Should We Cut?

Digestive Endoscopy, EarlyView.
Siew‐Fung Hau, Hon Chi Yip
wiley   +1 more source

Quality Upper Gastrointestinal Endoscopy in Australia and Aotearoa New Zealand: A Joint Position Statement

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Quality standards for upper gastrointestinal (UGI) endoscopy are required to identify key quality indicators that are relevant to Australasian endoscopic practice and local patient populations. Such standards will promote equitable access to high‐quality UGI endoscopy for appropriate indications across Australia and Aotearoa New Zealand.
Linda S. Yang, Abir Halder, Bronte A. Holt, Benedict Devereaux, Matthew Remedios, Neil Merrett, Marianne Lill, Zoe Raos, Malcolm Arnold, Nicholas G. Burgess, Sneha John, Krish Ragunath   +11 more
wiley   +1 more source

Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome

, 2000
M. Michael Wolfe, George Sachs
openalex   +1 more source

Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Delayed bleeding is a major concern after gastric endoscopic submucosal dissection (ESD), especially in patients taking antithrombotic agents. The aim of this study was to evaluate the superiority of vonoprazan (VPZ) over proton pump inhibitor (PPI) in preventing delayed bleeding after gastric ESD in patients taking ...
Hiroyuki Shibata, Toshihisa Fujiyoshi, Noboru Kawata, Tomohiko Obayashi, Masaya Esaki, Masakazu Kikuchi, Naohiro Yoshida, Tsuguo Kamioka, Yoji Sasaki, Makoto Kobayashi, Muneyori Okita, Shigeyuki Matsui, Kazuhiro Furukawa, Masanao Nakamura, Naomi Kakushima, Mitsuhiro Fujishiro, Hiroki Kawashima   +16 more
wiley   +1 more source

Development and validation of a screening instrument for gastroesophageal reflux disease (GERD) [PDF]

, 2000
Ofman J Joshua, Fullerton C Steve, Reyes B Eileen, Shaw J Michael, Grogg Amy, Kay Sadik   +5 more
openalex   +1 more source

Preferences Regarding Clinical Drug Trial Elements: A Nationally Representative Survey of Older Adults With Multimorbidity

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Older adults with multimorbidity have been under‐represented in clinical drug trials. We sought to determine willingness to enroll in trials and preferences of older adults for learning about clinical trials, visit frequency, travel, locations, and testing.
Janice B. Schwartz, Ruey‐Ying Liu, John Boscardin, Derjung M. Tarn   +3 more
wiley   +1 more source

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease [PDF]

, 2001
Melanie Shaw
openalex   +2 more sources

An Unusual Case of Chronic Cough: Is It Beyond Simple Gastroesophageal Reflux Disease? [PDF]

Cureus
Hughes G, Reynolds A, Yuenyongsagul K, Ayub S, Waheed A.   +4 more
europepmc   +1 more source

Rabeprazole relieves Symptom distress in patients with non-erosive Gastroesophageal reflux disease (GERD)

, 2000
Reshmi Siddique, Sheldon Sloan, Ming Zheng, Ashoke Bhattacharjya, John F. Johanson, Christina Farup   +5 more
openalex   +1 more source